Arrayjet Continue to Widen Global Sales Channels with New Distribution Deal
News Jun 07, 2013
Arrayjet Ltd has announced a new distribution deal with Sciencewerke Pte Ltd in South East Asia.
Arrayjet, a leader in microarray solutions, have expanded their global sales channels with the appointment of genomics and proteomics distributor Sciencewerke in South East Asia, with sales reach covering Singapore, Thailand, Malaysia and Indonesia.
Arrayjet has been in the microarray market since 2005 with the launch of the Marathon microarrayer, the first in a range of four microarray instruments utilizing the company's unique, non-contact inkjet technology.
Since then Arrayjet has developed the product range and diversified the offering with the launch of Arrayjet Advance microarray services in 2011.
Arrayjet Commercial Director, Claire Jenkins commented; ''with worldwide customers and a user base spanning 16 countries, selecting the right distribution partners is essential for Arrayjet. We are excited to have appointed Sciencewerke who have a great understanding of the microarray and biochip market in South East Asia. We look forward to working with them to support our existing customer base and to accelerate growth in this territory''.
Sciencewerke commented; ''we started out with a strong focus in microarray related products that included reagents and consumables for microarray labelling, substrates, array scanners, automated hybridization stations and bioinformatics software. Over the years, we’ve strengthened our product portfolio to also include a full suite of genomics services for microarray full service, NGS, low and high throughput SNP genotyping and more. With our knowledge, expertise and experience in microarray related products and services, and our strong presence in South East Asia, I’m sure we will be able to provide Arrayjet a strong springboard to propel and reach out to the clientele in this region''.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.